RTW INVESTMENTS, LP
CIK 1493215 · Lihat di SEC EDGAR ↗
- Nilai Portofolio
- $11.7B
- Posisi
- 84
- Per tanggal
- 30 Juni 2026
#430 dari 9.443 berdasarkan nilai 13F · top 4.6%
Nilai portofolio QoQ: +16.5% 13F tidak mengungkapkan kas
- Bobot 10 kepemilikan teratas
- 47,72%
- Bobot 25 kepemilikan teratas
- 77,26%
- Posisi di atas 1%
- 32
- Jumlah posisi efektif
- 29,6
Berdasarkan kepemilikan ekuitas jangka panjang 13F saja (kas, obligasi, posisi jual tidak diungkapkan)
Perputaran Q2 2026: 10,33% Perkiraan pembelian $1.165.745.587 · penjualan $1.123.936.325
Kepemilikan median: 4,0 kuartal Dilacak Q4 2024–Q2 2026 · 59,2% masih dipegang
- Posisi baru
- 9
- Meningkat
- 26
- Menurun
- 8
- Tertutup
- 13
Di halaman ini
- Kinerja vs S&P Bagaimana portofolio 13F manajer ini berkinerja terhadap S&P 500.
- Rincian sektor Bagaimana portofolio terbagi di berbagai sektor pasar.
- Portofolio Setiap saham yang dilaporkan dimiliki oleh institusi ini, dari 13F terbarunya.
- Taruhan Bernilai Tinggi Kepemilikan yang paling terkonsentrasi pada manajer ini.
- Taruhan baru terbesar Posisi baru yang dibuka pada kuartal terakhir.
- Pergerakan Teratas Peningkatan dan penurunan posisi terbesar pada kuartal ini.
- Posisi yang keluar Posisi yang sepenuhnya dijual oleh manajer pada kuartal lalu.
- Terkait Orang di balik pengaju ini, jika kami dapat mencocokkannya.
Kinerja vs S&P 500
Tahunan: +46.2% · S&P 500: +18.0%
Perkiraan portofolio beli-dan-tahan yang dibangun dari snapshot 13F SEC triwulanan. Mengecualikan kas, posisi jual, opsi/derivatif, dan sekuritas non-13(f) — mencerminkan buku ekuitas long yang diungkapkan saja, bukan total AUM dana. Keterlambatan pengajuan SEC hingga 45 hari; ini bukan waktu yang dapat disalin secara real-time.
Cakupan yang dapat dihargai: 98,8% · Opsi dikecualikan: 0,0%
Rincian sektor
Healthcare
97,2%
N/A
0,1%
Lainnya/Tidak terpetakan
2,7%
Portofolio lengkap 84 posisi
| Tipe | Rentetan | Tren 8 kuartal | |||||
|---|---|---|---|---|---|---|---|
| MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | $1.070.510.235 | 9,14% | 1.993.687 | $26.874.901 | |||
| ARGX argenx SE - American Depositary Shares | $658.202.715 | 5,62% | 709.446 | $140.129.773 | |||
| PTCT PTC Therapeutics, Inc. - Common Stock | $631.875.072 | 5,39% | 7.746.415 | $104.111.818 | |||
| PTGX Protagonist Therapeutics, Inc. - Common Stock | $620.398.832 | 5,30% | 5.061.175 | $87.174.646 | Naik ×1 | ||
| CGON CG Oncology, Inc. - Common stock | $604.961.620 | 5,16% | 8.514.590 | $132.229.815 | Naik ×3 | ||
| INSM Insmed Incorporated - Common Stock | $516.347.866 | 4,41% | 4.842.880 | $-275.559.872 | |||
| TNGX Tango Therapeutics, Inc. - Common Stock | $434.533.381 | 3,71% | 13.900.620 | $156.284.411 | Naik ×2 | ||
| SYRE Spyre Therapeutics, Inc. - Common Stock | $377.492.205 | 3,22% | 4.251.996 | $167.056.727 | Naik ×1 | ||
| CELC Celcuity Inc. - Common Stock | $345.758.952 | 2,95% | 3.304.903 | $-1.183.389 | Naik ×2 | ||
| ERAS Erasca, Inc. - Common Stock | $328.784.533 | 2,81% | 17.946.754 | $67.361.441 | Naik ×2 | ||
| RDNT RadNet, Inc. - Common Stock | $298.911.900 | 2,55% | 4.846.958 | $59.423.250 | Naik ×6 | ||
| ORKA Oruka Therapeutics, Inc. - Common Stock | $298.741.485 | 2,55% | 3.139.030 | $197.789.326 | Naik ×1 | ||
| NTRA Natera, Inc. - Common Stock | $271.450.000 | 2,32% | 1.000.000 | $21.462.500 | Turun ×4 | ||
| RARE Ultragenyx Pharmaceutical Inc. - Common Stock | $260.338.324 | 2,22% | 7.796.895 | $183.896.069 | Naik ×2 | ||
| IRTC iRhythm Holdings, Inc. - Common Stock | $259.623.957 | 2,22% | 2.182.631 | $62.707.587 | Naik ×2 | ||
| CYTK Cytokinetics, Incorporated - Common Stock | $243.814.036 | 2,08% | 2.862.003 | $64.462.512 | Naik ×1 | ||
| Penerbit tidak dikenal (CUSIP: 482931102) | $237.413.345 | 2,03% | 10.776.820 | Naik ×1 | |||
| ESTA Establishment Labs Holdings Inc. - Common Shares | $227.885.188 | 1,95% | 2.655.695 | $77.094.826 | |||
| GH Guardant Health, Inc. - Common Stock | $222.199.381 | 1,90% | 1.481.033 | $85.396.363 | |||
| NBIX Neurocrine Biosciences, Inc. - Common Stock | $213.689.740 | 1,82% | 1.267.925 | $73.772.375 | Naik ×1 | ||
| TARS Tarsus Pharmaceuticals, Inc. - Common Stock | $211.293.293 | 1,80% | 3.357.059 | $-23.430.361 | Naik ×4 | ||
| STOK Stoke Therapeutics, Inc. - Common Stock | $184.001.738 | 1,57% | 5.623.525 | $899.764 | |||
| QURE uniQure N.V. - Ordinary Shares | $181.548.806 | 1,55% | 3.941.572 | $139.261.885 | Naik ×1 | ||
| ACAD ACADIA Pharmaceuticals Inc. - Common Stock | $180.756.457 | 1,54% | 7.144.524 | $21.719.353 | |||
| RGEN Repligen Corporation - Common Stock | $169.272.512 | 1,45% | 1.240.637 | $27.181.592 | Naik ×2 | ||
| URGN UroGen Pharma Ltd. - Ordinary Shares | $167.215.336 | 1,43% | 4.543.895 | $85.516.104 | |||
| GHRS GH Research PLC - Ordinary Shares | $159.500.947 | 1,36% | 5.933.815 | $76.071.508 | |||
| IMCR Immunocore Holdings plc - American Depositary Shares | $154.616.087 | 1,32% | 4.869.798 | $7.791.677 | |||
| CMPS COMPASS Pathways Plc - American Depository Shares | $151.418.782 | 1,29% | 10.700.974 | $92.621.665 | Naik ×6 | ||
| IMTX Immatics N.V. - Ordinary Shares | $131.144.763 | 1,12% | 12.946.176 | $4.510.457 | Naik ×6 | ||
| ZLAB Zai Lab Limited - American Depositary Shares | $124.906.608 | 1,07% | 6.574.032 | $1.249.066 | |||
| IMVT Immunovant, Inc. - Common Stock | $122.442.522 | 1,05% | 3.177.849 | $43.504.753 | |||
| BLTE Belite Bio, Inc - American Depositary Shares | $110.150.398 | 0,94% | 715.332 | $-3.902.136 | |||
| XNCR Xencor, Inc. - Common Stock | $109.117.122 | 0,93% | 6.777.461 | $27.380.942 | |||
| TSHA Taysha Gene Therapies, Inc. - Common Stock | $92.345.357 | 0,79% | 13.560.258 | $31.194.648 | Turun ×4 | ||
| COGT Cogent Biosciences, Inc. - Common Stock | $89.359.113 | 0,76% | 2.309.021 | $-120.745.288 | Turun ×2 | ||
| ALKS Alkermes plc - Ordinary Shares | $87.623.093 | 0,75% | 1.672.356 | $28.488.585 | |||
| GPCR Structure Therapeutics Inc. - American Depositary Shares | $86.274.901 | 0,74% | 1.607.507 | ||||
| REPL Replimune Group, Inc. - Common Stock | $82.046.202 | 0,70% | 7.411.581 | $25.765.795 | Naik ×4 | ||
| CSTL Castle Biosciences, Inc. - Common stock | $66.263.290 | 0,57% | 2.778.335 | $-1.453.834 | Naik ×2 | ||
| CADL Candel Therapeutics, Inc. - Common Stock | $66.146.785 | 0,56% | 6.422.018 | $34.678.897 | |||
| RCKT Rocket Pharmaceuticals, Inc. - Common Stock | $60.492.180 | 0,52% | 17.687.772 | $-2.830.044 | |||
| KOD Kodiak Sciences Inc - Common Stock | $57.969.909 | 0,49% | 1.487.934 | $1.249.865 | |||
| AKTS Aktis Oncology, Inc. - Common stock | $51.311.546 | 0,44% | 1.592.043 | $22.829.897 | |||
| AXGN Axogen, Inc. - Common Stock | $46.724.695 | 0,40% | 1.011.576 | Naik ×1 | |||
| DHR Danaher Corporation Common Stock | $43.810.400 | 0,37% | 230.000 | Naik ×1 | |||
| CGEM Cullinan Therapeutics, Inc. - Common Stock | $43.054.759 | 0,37% | 2.364.347 | $18.813.067 | Naik ×1 | ||
| NGNE Neurogene Inc. - Common Stock | $42.849.241 | 0,37% | 1.362.456 | $15.382.128 | |||
| HNGE Hinge Health, Inc. Class A Common Stock | $41.500.000 | 0,35% | 500.000 | $-32.920.800 | Turun ×1 | ||
| OBIO Orchestra BioMed Holdings, Inc. - Ordinary Shares | $41.234.412 | 0,35% | 9.556.063 | $5.933.644 | Naik ×1 | ||
| SLDB Solid Biosciences Inc. - Common Stock | $38.890.331 | 0,33% | 3.892.926 | Naik ×1 | |||
| SVRA Savara, Inc. - Common Stock | $36.666.661 | 0,31% | 5.952.380 | $4.166.666 | |||
| AQST Aquestive Therapeutics, Inc. - Common Stock | $30.894.119 | 0,26% | 7.426.471 | $74.264 | |||
| KYMR Kymera Therapeutics, Inc. - Common Stock | $27.520.800 | 0,23% | 240.000 | $7.531.200 | |||
| VSTM Verastem, Inc. - Common Stock | $25.348.729 | 0,22% | 6.635.793 | $-9.505.693 | Naik ×1 | ||
| DNTH Dianthus Therapeutics, Inc. - Common Stock | $24.181.181 | 0,21% | 248.063 | $3.363.734 | |||
| BBNX Beta Bionics, Inc. - Common Stock | $23.505.000 | 0,20% | 1.500.000 | $3.465.000 | Turun ×3 | ||
| IPSC Century Therapeutics, Inc. - Common Stock | $21.304.347 | 0,18% | 8.695.652 | $1.652.173 | |||
| EVMN Evommune, Inc. Common Stock | $19.964.703 | 0,17% | 1.502.235 | $-14.571.680 | |||
| BEAM Beam Therapeutics Inc. - Common Stock | $19.575.922 | 0,17% | 570.394 | $5.983.433 | |||
| DFTX Definium Therapeutics, Inc. - Common Shares | $18.816.000 | 0,16% | 400.000 | $13.146.000 | Naik ×1 | ||
| IDYA IDEAYA Biosciences, Inc. - Common Stock | $13.803.690 | 0,12% | 370.370 | ||||
| ATAI AtaiBeckley Inc. - Common Stock | $10.540.000 | 0,09% | 2.000.000 | $3.460.000 | |||
| MIST Milestone Pharmaceuticals Inc. - Common Shares | $10.496.670 | 0,09% | 7.833.336 | $2.962.779 | Naik ×2 | ||
| OCGN Ocugen, Inc. - Common Stock | $10.199.999 | 0,09% | 6.666.666 | $-1.866.666 | |||
| TENX Tenax Therapeutics, Inc. - Common Stock | $10.135.094 | 0,09% | 696.570 | $4.214.860 | Naik ×1 | ||
| HTFL Heartflow, Inc. - Common Stock | $8.655.300 | 0,07% | 295.000 | $-3.388.050 | Turun ×1 | ||
| PCSC Perceptive Capital Solutions Corp - Class A Ordinary Shares | $8.078.400 | 0,07% | 742.500 | $-66.825 | |||
| WVE Wave Life Sciences Ltd. - Ordinary Shares | $7.843.500 | 0,07% | 1.350.000 | $-1.944.000 | |||
| LRMR Larimar Therapeutics, Inc. - Common Stock | $7.826.297 | 0,07% | 2.565.999 | $1.076.297 | Naik ×1 | ||
| LMRI Lumexa Imaging Holdings, Inc. - Common Stock | $7.332.000 | 0,06% | 650.000 | $1.742.000 | |||
| ALLO Allogene Therapeutics, Inc. - Common Stock | $6.760.000 | 0,06% | 3.250.000 | Naik ×1 | |||
| CBIO Crescent Biopharma, Inc. - Common Stock | $6.711.408 | 0,06% | 372.856 | $-137.957 | |||
| FDMT 4D Molecular Therapeutics, Inc. - Common Stock | $6.327.302 | 0,05% | 475.737 | $1.898.191 | |||
| MAZE Maze Therapeutics, Inc. - Common Stock | $6.326.080 | 0,05% | 212.000 | Naik ×1 | |||
| CAPR Capricor Therapeutics, Inc. - Common Stock | $6.020.000 | 0,05% | 250.000 | $-1.580.000 | |||
| KLRS Kalaris Therapeutics, Inc. - Common Stock | $5.291.000 | 0,05% | 1.300.000 | $-2.210.000 | |||
| ABVX Abivax SA - American Depositary Shares | $3.518.064 | 0,03% | 26.400 | ||||
| AVTX Avalo Therapeutics, Inc. - Common Stock | $3.234.000 | 0,03% | 175.000 | $-9.560.443 | Turun ×1 | ||
| MDLN Medline Inc. - Class A common stock | $2.760.800 | 0,02% | 70.000 | $-354.200 | |||
| IRON Disc Medicine, Inc. - Common Stock | $2.194.200 | 0,02% | 30.000 | $276.000 | |||
| IMA ImageneBio, Inc. - Common Stock | $1.973.226 | 0,02% | 334.445 | $301.001 | |||
| XGN Exagen Inc. - Common Stock | $906.750 | 0,01% | 195.000 | $-278.943 | Turun ×3 | ||
| RCKTW Rocket Pharmaceuticals, Inc. - Warrant | $1.190 | 0,00% | 350.000 | $-6.020 | |||
| Tidak ada hasil | |||||||
Kepemilikan dengan keyakinan
Posisi meningkat selama 3+ kuartal berturut-turut.
Jumlah saham dilaporkan dalam pengajuan 13F (tidak disesuaikan split)
Taruhan baru terbesar
Posisi baru dibuka kuartal ini, terbesar diurutkan pertama.
| Sekuritas | Nilai | Saham | % dari portofolio |
|---|---|---|---|
| Penerbit tidak dikenal (CUSIP: 482931102) | $237.413.345 | 10.776.820 | 2,03% |
| GPCR | $86.274.901 | 1.607.507 | 0,74% |
| AXGN | $46.724.695 | 1.011.576 | 0,40% |
| DHR | $43.810.400 | 230.000 | 0,37% |
| SLDB | $38.890.331 | 3.892.926 | 0,33% |
| IDYA | $13.803.690 | 370.370 | 0,12% |
| ALLO | $6.760.000 | 3.250.000 | 0,06% |
| MAZE | $6.326.080 | 212.000 | 0,05% |
| ABVX | $3.518.064 | 26.400 | 0,03% |
Penggerak teratas (QoQ)
| Sekuritas | Aksi | Saham Δ | Nilai Δ |
|---|---|---|---|
| INSM | Hanya pergerakan harga | +0 | -$275.6M |
| ORKA | Beli lebih banyak | +1.1M | +$197.8M |
| RARE | Beli lebih banyak | +4.1M | +$183.9M |
| SYRE | Beli lebih banyak | +80K | +$167.1M |
| TNGX | Beli lebih banyak | +600K | +$156.3M |
| ARGX | Hanya pergerakan harga | +0 | +$140.1M |
| QURE | Beli lebih banyak | +1.4M | +$139.3M |
| CGON | Beli lebih banyak | +1.5M | +$132.2M |
| COGT | Dipangkas | -3.1M | -$120.7M |
| PTCT | Hanya pergerakan harga | +0 | +$104.1M |
Posisi yang keluar
Termasuk peristiwa perusahaan (merger, delisting) — tidak semua keluar adalah penjualan
Posisi tertutup mencerminkan perubahan pelaporan 13F; bagi manajer indeks, ini sering kali mekanis (penghapusan pencatatan, M&A, penyeimbangan ulang indeks), bukan keputusan aktif.
| Sekuritas | Kuartal | Saham sebelumnya | Nilai sebelumnya | Harga sejak keluar |
|---|---|---|---|---|
| RNA | 31 Des. 2025 | 11.372.829 | $495.514.160 | -81,8% |
| VRNA | 30 Sep. 2025 | 3.051.878 | $288.646.621 | Tidak lagi dilacak |
| PEN | 31 Maret 2026 | 866.499 | $269.403.204 | -1,3% |
| AKRO | 31 Des. 2025 | 5.477.561 | $260.074.596 | Tidak lagi dilacak |
| APGE | 30 Juni 2026 | 2.782.097 | $234.169.104 | 1,6% |
| MRUS | 31 Des. 2025 | 2.025.277 | $190.679.830 | Tidak lagi dilacak |
| AXSM | 31 Maret 2026 | 888.001 | $162.184.503 | 23,4% |
| APLS | 30 Juni 2026 | 3.685.045 | $148.249.360 | Tidak lagi dilacak |
| BRKR | 31 Maret 2025 | 2.481.119 | $145.443.196 | 41,2% |
| ISRG | 30 Juni 2026 | 220.000 | $101.417.800 | -6,1% |
| PODD | 31 Maret 2026 | 324.600 | $92.264.304 | -30,4% |
| MASI | 31 Maret 2026 | 683.294 | $88.869.218 | Tidak lagi dilacak |
| GMED | 30 Juni 2025 | 1.125.000 | $82.350.000 | 44,5% |
| CNTA | 30 Juni 2026 | 2.054.175 | $81.591.831 | Tidak lagi dilacak |
| ABT | 30 Sep. 2025 | 444.000 | $60.388.440 | -14,6% |
| RAPT | 31 Maret 2026 | 1.637.165 | $55.450.779 | Tidak lagi dilacak |
| CRNX | 30 Juni 2026 | 1.451.326 | $52.712.160 | 126,5% |
| DGX | 31 Des. 2025 | 250.000 | $47.645.000 | 38,6% |
| LENZ | 31 Des. 2025 | 863.389 | $40.216.660 | -70,1% |
| WAY | 30 Juni 2026 | 1.630.000 | $39.299.300 | 20,7% |
| ARWR | 30 Juni 2026 | 585.682 | $36.722.261 | 8,2% |
| DYN | 31 Des. 2025 | 2.890.567 | $36.565.673 | 34,9% |
| SLNO | 30 Sep. 2025 | 424.408 | $35.556.902 | Tidak lagi dilacak |
| MLTX | 30 Sep. 2025 | 741.090 | $34.979.448 | 121,2% |
| SYK | 30 Juni 2026 | 100.000 | $32.859.000 | 5,0% |
| ABVX | 31 Des. 2025 | 350.000 | $29.715.000 | -11,4% |
| GEHC | 31 Des. 2025 | 393.500 | $29.551.850 | -9,7% |
| ARVN | 30 Juni 2025 | 3.334.308 | $23.406.842 | 24,0% |
| CMPX | 30 Juni 2026 | 4.186.599 | $22.147.109 | 10,3% |
| ALEC | 31 Des. 2025 | 6.990.806 | $20.692.786 | 45,8% |
| FLGT | 30 Juni 2026 | 1.289.000 | $20.495.100 | -4,1% |
| ETNB | 30 Sep. 2025 | 1.967.527 | $19.321.115 | Tidak lagi dilacak |
| GKOS | 30 Juni 2025 | 190.000 | $18.699.800 | 78,9% |
| ROIV | 31 Maret 2025 | 1.454.273 | $17.204.050 | 266,8% |
| SAGE | 31 Maret 2025 | 3.002.370 | $16.302.869 | Tidak lagi dilacak |
| TRML | 31 Maret 2025 | 736.681 | $14.939.891 | Tidak lagi dilacak |
| DNTH | 31 Maret 2025 | 666.667 | $14.533.341 | 516,3% |
| IMVT | 31 Maret 2025 | 530.614 | $13.143.309 | 160,6% |
| PEPG | 31 Maret 2025 | 3.193.097 | $12.101.838 | 123,5% |
| TEM | 31 Maret 2026 | 200.000 | $11.810.000 | 46,8% |
| CTMX | 31 Des. 2025 | 3.461.500 | $11.042.185 | -20,7% |
| IQV | 31 Maret 2026 | 46.000 | $10.368.860 | 50,2% |
| BEAM | 30 Juni 2025 | 438.659 | $8.567.010 | 71,5% |
| JBIO | 30 Juni 2026 | 573.205 | $8.053.530 | -3,1% |
| ALUR | 31 Maret 2026 | 5.891.430 | $7.246.459 | Tidak lagi dilacak |
| IVA | 30 Juni 2026 | 1.298.702 | $7.207.796 | 25,4% |
| GPCR | 31 Maret 2026 | 100.000 | $6.955.000 | 5,5% |
| PEPG | 31 Des. 2025 | 1.500.000 | $6.930.000 | -51,8% |
| IDYA | 31 Maret 2025 | 200.000 | $5.140.000 | 147,5% |
| CRGX | 30 Sep. 2025 | 1.212.562 | $4.995.755 | Tidak lagi dilacak |
| IMUX | 31 Maret 2025 | 4.567.717 | $4.567.717 | 1415,1% |
| MNMD | 31 Maret 2026 | 300.000 | $4.017.000 | Tidak lagi dilacak |
| CRVS | 31 Maret 2026 | 447.607 | $3.446.574 | -0,4% |
| GPCR | 31 Maret 2025 | 125.000 | $3.390.000 | 193,8% |
| KMTS | 30 Sep. 2025 | 200.000 | $3.316.000 | 14,6% |
| SLRN | 31 Maret 2025 | 978.310 | $3.071.893 | Tidak lagi dilacak |
| BIOA | 30 Juni 2025 | 786.353 | $2.956.687 | 136,6% |
| CBLL | 30 Sep. 2025 | 150.000 | $2.809.500 | 108,4% |
| RGNX | 31 Maret 2025 | 350.000 | $2.705.500 | 53,6% |
| OMDA | 30 Juni 2026 | 200.000 | $2.514.000 | 7,7% |
| EPIX | 31 Maret 2025 | 1.113.002 | $1.992.274 | Tidak lagi dilacak |
| ARTV | 31 Maret 2025 | 148.844 | $1.500.348 | 278,7% |
| ADGM | 31 Des. 2025 | 209.361 | $406.160 | -37,9% |
| IMUX | 30 Sep. 2025 | 402.107 | $280.470 | 1772,4% |